The keys to diagnosing interstitial lung disease: Part 2

Journal of Respiratory Diseases

Volumn 26, Issue 10, 2005, Pages 443-448

  Neralla, Sridhar ^a   Meyer, Keith C ^a  

^a University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN;

ALLERGIC PNEUMONITIS; CHRONIC DISEASE; COUGHING; DYSPNEA; EXPOSURE; FLU LIKE SYNDROME; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; LUNG FIBROSIS; LUNG GRANULOMA; LUNG NODULE; LUNG SARCOIDOSIS; LYMPHADENOPATHY; MOULD; PIGEON; REVIEW; SJOEGREN SYNDROME; SYMPTOMATOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; THORAX RADIOGRAPHY;

EID: 27744586029     PISSN: 0194259X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Newman LS, Rose CS, Maier LA, Sarcoidosis. N Engl J Med. 1997;336:1224-1234.
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granutomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ETS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736-755.
3. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax. 1996;51:238-247.
4. Grenier P, Chevret S, Beigelman C, et al. Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesin analysis. Radiology. 1994;191:383-390.
5. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med. 1983;52:525-633.
6. Selman M. Hypersensitivity pneumonitis. In: Schwarz MI, King TE Jr, eds. Interstitial Lung Disease. 4th ed. London: BC Decker; 2003:452-484.
7. Lacasse Y, Selman M, Costabel U, et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2003;168:952-958.
8. Webb WR, Müller NL, Naidich DR eds. Hypersensitivity pneumonitis. In: High-Resolution CT of the Lung, 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2001:355-366.
9. Costabel U, Guzman J. Less common diseases: hypersensitivity pnemonitis. In: Baughman RP, du Bois RM, Lynch JP III, eds. Diffuse Lung Disease: A Practical Approach. London: Arnold; 2004:203-212.
10. De Vuyst P, Camus P. The past and present of pneumoconioses. Curr Opin Pulm Med. 2000;6:151-156.
11. Blumberg HM, Burman WJ, Chaisson RE, et al: American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med. 2003;167:603-662.
12. Rom WN, Travis WD, Brady AR. Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis. 1991;143:408-422.
13. Craighead JE, Abraham JL, Churg A, et al. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med. 1982;106:544-596.
14. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir. Crit Care Med. 2004;170:691-715.
15. Schwartz DA, Fuortes LJ, Galvin JR, et al. Asbestos-induced pleural fibrosis and impaired lung function. Am Rev Respir Dis. 1990;141:321-326.
16. Staples CA, Gamsu G, Ray CS, Webb WR. High resolution computed tomography and lung function in asbestos-exposed workers with normal chest radiographs. Am Rev Respir Dis. 1989;139:1502-1508.
17. Akira M. High-resolution CT in the evaluation of occupational and environmental disease. Radiol Clin North Am. 2002;40:43-59.